Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit)

v3.21.2
Condensed Consolidated Statement of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Note Receivable [Member]
Accumulated Deficit [Member]
Total [Member]
Beginning Balance at Dec. 31, 2019 $ (60,361) $ 136,797 $ 4 $ 2,008 $ (624) $ (170) $ (61,579) $ 76,436
Beginning Balance, Shares at Dec. 31, 2019   107,452,541 37,385,121   233,007      
Exercise of common stock options 600     430   170   600
Exercise of common stock options, Shares     809,489          
Stock-based compensation expense 504     504       504
Exercise of Series D warrants   $ 50           50
Exercise of Series D warrants, Shares   10,018            
Net profit (loss) and comprehensive income (loss) (5,245)           (5,245) (5,245)
Ending Balance at Mar. 31, 2020 (64,502) $ 136,847 $ 4 2,942 $ (624) 0 (66,824) 72,345
Ending Balance, Shares at Mar. 31, 2020   107,462,558 38,194,610   233,007      
Beginning Balance at Dec. 31, 2019 (60,361) $ 136,797 $ 4 2,008 $ (624) (170) (61,579) 76,436
Beginning Balance, Shares at Dec. 31, 2019   107,452,541 37,385,121   233,007      
Net profit (loss) and comprehensive income (loss) (14,653)              
Ending Balance at Sep. 30, 2020 (72,659) $ 137,147 $ 4 4,193 $ (624) 0 (76,232) 64,488
Ending Balance, Shares at Sep. 30, 2020   107,522,670 38,908,504   233,007      
Beginning Balance at Mar. 31, 2020 (64,502) $ 136,847 $ 4 2,942 $ (624) 0 (66,824) 72,345
Beginning Balance, Shares at Mar. 31, 2020   107,462,558 38,194,610   233,007      
Exercise of common stock options 55     55       55
Exercise of common stock options, Shares     337,846          
Stock-based compensation expense 503     503       503
Exercise of Series D warrants   $ 300           300
Exercise of Series D warrants, Shares   60,112            
Net profit (loss) and comprehensive income (loss) (5,689)           (5,689) (5,689)
Ending Balance at Jun. 30, 2020 (69,633) $ 137,147 $ 4 3,500 $ (624) 0 (72,513) 67,514
Ending Balance, Shares at Jun. 30, 2020   107,522,670 38,532,456   233,007      
Exercise of common stock options 172     172       172
Exercise of common stock options, Shares     376,048          
Stock-based compensation expense 521     521       521
Net profit (loss) and comprehensive income (loss) (3,719)           (3,719) (3,719)
Ending Balance at Sep. 30, 2020 (72,659) $ 137,147 $ 4 4,193 $ (624) 0 (76,232) 64,488
Ending Balance, Shares at Sep. 30, 2020   107,522,670 38,908,504   233,007      
Beginning Balance at Dec. 31, 2020 (75,472) $ 137,497 $ 4 5,538 $ (1,450) (79,564) 62,025
Beginning Balance, Shares at Dec. 31, 2020   107,592,801 39,510,108   483,479      
Exercise of common stock options 356     356       356
Exercise of common stock options, Shares     714,170          
Stock-based compensation expense 1,195     1,195       1,195
Exercise of Series D warrants   $ 100           100
Exercise of Series D warrants, Shares   20,037            
Net profit (loss) and comprehensive income (loss) (10,020)           (10,020) (10,020)
Ending Balance at Mar. 31, 2021 (83,941) $ 137,597 $ 4 7,089 $ (1,450) (89,584) 53,656
Ending Balance, Shares at Mar. 31, 2021   107,612,838 40,224,277   483,479      
Beginning Balance at Dec. 31, 2020 (75,472) $ 137,497 $ 4 5,538 $ (1,450) (79,564) 62,025
Beginning Balance, Shares at Dec. 31, 2020   107,592,801 39,510,108   483,479      
Net profit (loss) and comprehensive income (loss) 594              
Ending Balance at Sep. 30, 2021 233,133 $ 0 $ 19 312,084 $ 0 0 (78,970) 233,133
Ending Balance, Shares at Sep. 30, 2021   0 185,697,959   0      
Beginning Balance at Mar. 31, 2021 (83,941) $ 137,597 $ 4 7,089 $ (1,450) (89,584) 53,656
Beginning Balance, Shares at Mar. 31, 2021   107,612,838 40,224,277   483,479      
Exercise of common stock options 62     62       62
Exercise of common stock options, Shares     102,237          
Stock-based compensation expense 1,779     1,779       1,779
Exercise of Series D warrants   $ 355           355
Exercise of Series D warrants, Shares   71,139            
Exercise of common stock warrants, net of shares withheld for exercise 1,793     1,793       1,793
Exercise of common stock warrants, net of shares withheld for exercise, Shares     179,572          
Net profit (loss) and comprehensive income (loss) (11,089)           (11,089) (11,089)
Ending Balance at Jun. 30, 2021 (91,396) $ 137,952 $ 4 10,723 $ (1,450) (100,673) 46,556
Ending Balance, Shares at Jun. 30, 2021   107,683,977 40,506,086   483,479      
Exercise of common stock options 1,309     1,309       1,309
Exercise of common stock options, Shares     1,016,004          
Stock-based compensation expense 2,800     2,800       2,800
Exercise of Series D warrants   $ 95           95
Exercise of Series D warrants, Shares   19,036            
Conversion of convertible preferred stock into common stock upon reverse recapitalization, converted   $ 138,047            
Conversion of convertible preferred stock into common stock upon reverse recapitalization, converted, Shares   107,703,013            
Conversion of convertible preferred stock into common stock upon reverse recapitalization, issued 138,047   $ 11 138,036        
Conversion of convertible preferred stock into common stock upon reverse recapitalization, issued, Shares     107,703,013          
Retirement of Treasury Stock upon reverse recapitalization       (1,450) $ 1,450      
Retirement of Treasury Stock upon reverse recapitalization, Shares     (483,479)   (483,479)      
Repurchase of common stock upon reverse recapitalization (45,000)     (45,000)       (45,000)
Repurchase of common stock upon reverse recapitalization, Shares     (4,499,998)          
Issuance of common stock upon the reverse recapitalization, net of transaction costs 113,178   $ 2 113,176       113,178
Issuance of common stock upon the reverse recapitalization, net of transaction costs, Shares     20,456,333          
Issuance of common stock related to PIPE Investment 210,000   $ 2 209,998       210,000
Issuance of common stock related to PIPE Investment, Shares     21,000,000          
Recognition of derivative liability related to earnout (123,129)     (123,129)       (123,129)
Earnout stock-based compensation expense 5,621     5,621       5,621
Net profit (loss) and comprehensive income (loss) 21,703           21,703 21,703
Ending Balance at Sep. 30, 2021 $ 233,133 $ 0 $ 19 $ 312,084 $ 0 $ 0 $ (78,970) $ 233,133
Ending Balance, Shares at Sep. 30, 2021   0 185,697,959   0